Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Researchers track Long-Term effects of experimental cancer therapy

NCT ID NCT06701201

First seen Jan 17, 2026 · Last updated May 22, 2026 · Updated 16 times

Summary

This study follows up to 60 adults who have already received an experimental cancer treatment called SynKIR CAR T cells. The goal is to monitor long-term safety and check how well the therapy continues to work over time. Participants do not receive any new treatment in this study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Colorado Blood Cancer Institute, part of Sarah Cannon Research Institute

    Denver, Colorado, 80218, United States

  • MD Anderson Cancer Center

    Houston, Texas, 77030, United States

  • University of Kansas Cancer Center

    Westwood, Kansas, 66205, United States

  • University of Pennsylvania Abramson Cancer Center

    Philadelphia, Pennsylvania, 19104, United States

  • University of Wisconsin Carbone Cancer Center

    Madison, Wisconsin, 53792, United States

  • Winship Cancer Institute of Emory University

    Atlanta, Georgia, 30322, United States

Conditions

Explore the condition pages connected to this study.